AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRON CORP LTD-CDI

0.660

-0.040-5.71%

Volume:169.75K

Turnover:112.15K

Market Cap:278.42M

PE:6.79

High:0.700

Open:0.700

Low:0.645

Close:0.700

52wk High:1.340

52wk Low:0.390

Shares:421.84M

Float Shares:52.30M

Volume Ratio:0.92

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.097

EPS(LYR):0.097

ROE:19.46%

ROA:-4.72%

PB:2.28

PE(LYR):6.79

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Assessing AptarGroup (ATR) Valuation After New Nasal Vaccine And Eye Care Technology Developments

Simply Wall St.

Astron Ltd-Appointment of Non-Executive Director

THOMSON REUTERS

A Look At AptarGroup (ATR) Valuation After Ave Maria Growth Fund Highlights Undervaluation And Industry Leadership

Simply Wall St.

Is AptarGroup (ATR) Quietly Reframing Its Pharma Story Around Data‑Driven Health Platforms?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ATR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATR.AU\",,,,,undefined,":{"symbol":"ATR.AU","market":"AU","secType":"STK","nameCN":"ASTRON CORP LTD-CDI","latestPrice":0.66,"timestamp":1770354720000,"preClose":0.7,"halted":0,"volume":169750,"delay":0,"changeRate":-0.05714285714285704,"nameEN":"ASTRON CORP LTD-CDI","floatShares":52304603,"shares":421844105,"eps":0.097193,"marketStatus":"Market Closed","change":-0.04,"latestTime":"02-06 16:12:00 AEDT","open":0.7,"high":0.7,"low":0.645,"amount":112147,"amplitude":0.078571,"askPrice":0.7,"askSize":170071,"bidPrice":0.65,"bidSize":34192,"shortable":3,"etf":0,"ttmEps":0.097193,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.7,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":0.9197052616739061,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATR.AU\",,,,,undefined,":{"symbol":"ATR.AU","floatShares":52304603,"roa":"-4.72%","roe":"19.46%","lyrEps":0.097193,"volumeRatio":0.9197052616739061,"shares":421844105,"dividePrice":0,"high":0.7,"amplitude":0.078571,"preClose":0.7,"low":0.645,"week52Low":0.39,"pbRate":"2.28","psRate":"25.38","week52High":1.34,"institutionHeld":0,"latestPrice":0.66,"committee":-0.665216,"eps":0.097193,"divideRate":0,"volume":169750,"delay":0,"ttmEps":0.097193,"open":0.7,"prevYearClose":0.7,"prevWeekClose":0.7,"prevMonthClose":0.7,"prevQuarterClose":0.7,"fiveDayClose":0.7,"twentyDayClose":0.735,"sixtyDayClose":0.7,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-08-21","symbol":"ATR.AU","reason":null,"defaultRemindTime":1755734400000,"announcedDate":"2025-08-19","type":"delisting","dateTimestamp":1755698400000},{"market":"AU","date":"2024-10-21","symbol":"ATR.AU","defaultRemindTime":1729465200000,"type":"split","dateTimestamp":1729429200000,"forFactor":997192,"toFactor":1000000,"ratio":0.997192},{"date":"2023-04-30","symbol":"ATR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682812800000,"name":null,"time":"","dateTimestamp":1682776800000,"actualEps":null},{"date":"2023-02-28","symbol":"ATR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677538800000,"name":null,"time":"","dateTimestamp":1677502800000,"actualEps":null},{"date":"2023-01-30","symbol":"ATR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604132876","title":"Assessing AptarGroup (ATR) Valuation After New Nasal Vaccine And Eye Care Technology Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2604132876","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604132876?lang=en_us&edition=fundamental","pubTime":"2026-01-19 21:11","pubTimestamp":1768828270,"startTime":"0","endTime":"0","summary":"AptarGroup (ATR) is back in focus after its LuerVax and Spray Divider nasal devices were selected for CastleVax’s Phase II intranasal COVID-19 vaccine trial, along with renewed attention on its Beat the Blink eye care platform.\nSee our latest analysis for AptarGroup.\nDespite the fresh attention on its nasal vaccine and eye care platforms, AptarGroup’s share price has been relatively muted, with a 2.73% 1 month share price return and a 1.77% year to date share price return. The 1 year total...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/assessing-aptargroup-atr-valuation-after-new-nasal-vaccine-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/assessing-aptargroup-atr-valuation-after-new-nasal-vaccine-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ATR.AU","ATR","BK4126","BK7095"],"gpt_icon":0},{"id":"2602568020","title":"Astron Ltd-Appointment of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2602568020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602568020?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:17","pubTimestamp":1768169841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nTUE6MF1RV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ATR.AU"],"gpt_icon":0},{"id":"2602552366","title":"A Look At AptarGroup (ATR) Valuation After Ave Maria Growth Fund Highlights Undervaluation And Industry Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2602552366","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602552366?lang=en_us&edition=fundamental","pubTime":"2026-01-11 23:17","pubTimestamp":1768144652,"startTime":"0","endTime":"0","summary":"AptarGroup (ATR) has attracted fresh attention after Ave Maria Growth Fund both initiated a position and highlighted the company as a top idea, while management recently outlined dates for its 2026 quarterly earnings conference calls.\nSee our latest analysis for AptarGroup.\nAptarGroup’s recent investor attention and 2026 earnings call schedule sit against a mixed picture, with a 1-day share price return of 1.15% to US$123.85, a 90-day share price return decline of 4.89%, and a 3-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/a-look-at-aptargroup-atr-valuation-after-ave-maria-growth-fu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/a-look-at-aptargroup-atr-valuation-after-ave-maria-growth-fu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ATR","BK4126","BK7095","ATR.AU"],"gpt_icon":0},{"id":"2602770803","title":"Is AptarGroup (ATR) Quietly Reframing Its Pharma Story Around Data‑Driven Health Platforms?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602770803","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602770803?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:22","pubTimestamp":1767968546,"startTime":"0","endTime":"0","summary":"Aptar Digital Health, a division of AptarGroup, recently partnered with ŌURA to connect its Migraine Buddy app with the Oura Ring, while Ave Maria Growth Fund disclosed a new position in AptarGroup, highlighting its global dispensing technology franchise and long-term potential despite near-term challenges.\nTogether, this digital health collaboration and endorsement from a growth-focused fund underscore how AptarGroup is extending its reach beyond physical drug delivery hardware into...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/is-aptargroup-atr-quietly-reframing-its-pharma-story-around","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/is-aptargroup-atr-quietly-reframing-its-pharma-story-around","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ATR.AU","ATR","BK7095","BK4126"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ATR.AU\",params:#limit:6,delay:true,,,undefined,":[]}}